Abstract 4363350: Long-Term Outcomes in Adults with Double Outlet Right Ventricle: A Multi-centred Cohort Study

O Omar Mubarak (University of Birmingham, Birmingham, United Kingdom) A Andrew Constantine (Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, UK, Birmingham, United Kingdom) S Saadiq Moledina (Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, UK, Birmingham, United Kingdom) A Alexander Kempny (Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Royal Brompton&Harefield NHS Foundation Trust, London, UK, London, United Kingdom) I Isma Rafiq W Wei Li S Sonya Babu-Narayan (Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Royal Brompton&Harefield NHS Foundation Trust, London, UK, London, United Kingdom) M Michael Gatzoulis (Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Royal Brompton&Harefield NHS Foundation Trust, London, UK, London, United Kingdom) L Lucy Hudsmith (Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, UK, Birmingham, United Kingdom) N Nada Al-Sakini (Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, UK, Birmingham, United Kingdom) M Margarita Brida (Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Royal Brompton&Harefield NHS Foundation Trust, London, UK, London, United Kingdom) S Sarah Ghonim (Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Royal Brompton&Harefield NHS Foundation Trust, London, UK, London, United Kingdom) S Sarah Bowater (Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, UK, Birmingham, United Kingdom) S Sara Thorne (Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Royal Brompton&Harefield NHS Foundation Trust, London, UK, London, United Kingdom) E Ee Ling Heng (Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Royal Brompton&Harefield NHS Foundation Trust, London, UK, London, United Kingdom) S Saqya Arif (Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, UK, Birmingham, United Kingdom) P Paul Clift (Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, UK, Birmingham, United Kingdom) K Konstantinos Dimopoulos

Abstract

Introduction: Double Outlet Right Ventricle (DORV) encompasses a heterogenous range of congenital heart diseases (CHD). While survival to adulthood has improved, the risk of long-term sequelae such as life-threatening arrhythmias and sudden cardiac death (SCD) remains significant. In this study, we present the most comprehensive follow-up of adults with DORV to date. Methods: This multi-centre, retrospective cohort study enrolled adults with CHD under follow-up at two tertiary cardiac centres in the United Kingdom from 2000-2023. DORV patients were eligible irrespective of surgical outcomes. Patients were grouped according to the following classification: group 1 (VSD-type), group 2 (Fallot-type), group 3 (transposition of the great arteries with pulmonary stenosis), group 4 (transposition of the great arteries without pulmonary stenosis), group 5 (B1-remote VSD; B2-univentricular physiology, unrepaired cases). The primary composite outcome for the study was all-cause mortality, heart transplantation, aborted SCD, or appropriate ICD shock. Results: Among 254 patients (median age 20 years; 52.8% male), 62.2% underwent biventricular repair. All DORV anatomical groups were present: Group 1 (n=34, 13.4%); Group 2 (n=76, 29.9%); Group 3 (n= 23, 9.1%); Group 4 (n=30, 11.8%); Group 5-B1 (n=5, 2%) and Group 5-B2 (n=86, 33.9%). Over a median follow-up of 12.4[7.4-17.3] years, 47 patients died, with heart failure (38.3%) and SCD (27.7%) as the leading causes. There were 4(1.6%) cases of aborted SCD; 4(1.6%) patients received a heart transplant and appropriate ICD shocks were delivered in 10(4.0%) patients. Arrhythmias were common, with 13% of patients developing ventricular tachycardia and 29.5% developing supraventricular tachycardia (SVT) during follow-up. Age, pulmonary hypertension, baseline QRS >180ms, non-sinus rhythm, SVT history, Rastelli operation and number of reparative surgeries were univariate predictors of poor outcome in patients with biventricular repair. On multivariate analysis, age, pulmonary hypertension and baseline QRS >180ms remained as negative prognostic indicators. (Table 1) Conclusion: In adult survivors of DORV, late mortality is driven by SCD and heart failure, and transplant was rarely achieved in our cohort. Strong predictors of adverse outcome include failure to achieve a repair, advancing age and pulmonary hypertension. Life-long, specialist surveillance of these patients is essential for risk stratification and timely intervention.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (18)

O

Omar Mubarak

University of Birmingham, Birmingham, United Kingdom

A

Andrew Constantine

Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, UK, Birmingham, United Kingdom

S

Saadiq Moledina

Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, UK, Birmingham, United Kingdom

A

Alexander Kempny

Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Royal Brompton&Harefield NHS Foundation Trust, London, UK, London, United Kingdom

I

Isma Rafiq

W

Wei Li

S

Sonya Babu-Narayan

Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Royal Brompton&Harefield NHS Foundation Trust, London, UK, London, United Kingdom

M

Michael Gatzoulis

Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Royal Brompton&Harefield NHS Foundation Trust, London, UK, London, United Kingdom

L

Lucy Hudsmith

Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, UK, Birmingham, United Kingdom

N

Nada Al-Sakini

Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, UK, Birmingham, United Kingdom

M

Margarita Brida

Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Royal Brompton&Harefield NHS Foundation Trust, London, UK, London, United Kingdom

S

Sarah Ghonim

Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Royal Brompton&Harefield NHS Foundation Trust, London, UK, London, United Kingdom

S

Sarah Bowater

Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, UK, Birmingham, United Kingdom

S

Sara Thorne

Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Royal Brompton&Harefield NHS Foundation Trust, London, UK, London, United Kingdom

E

Ee Ling Heng

Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Royal Brompton&Harefield NHS Foundation Trust, London, UK, London, United Kingdom

S

Saqya Arif

Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, UK, Birmingham, United Kingdom

P

Paul Clift

Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, UK, Birmingham, United Kingdom

K

Konstantinos Dimopoulos